Revvity, Inc.

Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Revvity (RVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo Finance · 28/07/2026 · lire l'article ↗

Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs

RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.

Yahoo Finance · 24/07/2026 · lire l'article ↗

Revvity to Launch Signals for Startups for Emerging Biotech Companies

RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.

Yahoo Finance · 22/07/2026 · lire l'article ↗

Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure

WALTHAM, Mass., July 20, 2026--Revvity, Inc. (NYSE: RVTY) today published its 2026 Impact Report, highlighting the Company’s sustainability, social and governance strategy, initiatives and performance. The annual report showcases how the Company continues to translate innovation into real-world impact, while embedding responsible and sustainable practices through its operations.

Yahoo Finance · 20/07/2026 · lire l'article ↗

Revvity Launches "Signals for Startups" to Help Emerging Biotechs Build Scalable Digital Foundations from Day One

WALTHAM, Mass., July 20, 2026--Revvity, Inc. announced that its Revvity Signals Software business is launching Signals for Startups, a new program designed to help emerging biotechnology companies adopt scalable informatics capabilities earlier in their growth journey. Built for early-stage biotechs, the program combines access to enterprise-grade Signals software with guided onboarding and best-practice configurations tailored specifically for smaller biotechs to help accelerate innovation, imp

Yahoo Finance · 20/07/2026 · lire l'article ↗

Should Revvity’s (RVTY) Claude Integration Reframe How Investors View Its Data and AI Strategy?

In early July 2026, Anthropic announced that Revvity Signals Software joined its Model Context Protocol connector directory, allowing scientists to access Signals AI and connected R&D knowledge directly through Claude, including the Claude Science workbench. This move links Claude’s reasoning tools with Revvity’s governed, ontology-driven scientific data, potentially making AI-driven discovery workflows more accessible to life sciences researchers who already rely on Revvity’s Signals...

Yahoo Finance · 10/07/2026 · lire l'article ↗